Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biomarkers in Prostate Cancer Treated With Salvage Radical Prostatectomy Following Failure of Focal Ablative Therapies

NCT03533998 is registered in ClinicalTrials.gov with Institut Mutualiste Montsouris as lead sponsor.

NCT NCT03533998
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03533998 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biomarkers in Prostate Cancer Treated With Salvage Radical Prostatectomy Following Failure of Focal Ablative Therapies
Lead sponsor
Institut Mutualiste Montsouris
Phase
Observational
Overall status
Unknown status
Start date
May 31, 2018
Completion date
September 30, 2018
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostatic neoplasms